Recent observational studies show a slightly increased risk of venous thromboembolism
among users of newer combined oral contraceptives with odds ratios between 0.8 and 2.3 …

Oral contraceptives are one of the most highly effective forms of contraception and provide
many short-and long-term noncontraceptive health benefits. They control menstrual cycle …

Recent epidemiological studies have reported an approximately two-fold, significant,
increased odds ratio for venous thromboembolism in users of third-generation oral …

Recent epidemiologic studies reported that the risk of venous thromboembolism (VTE) was
higher with the use of the newer third generation oral contraceptives than with second …

OBJECTIVE: To evaluate the risks and benefits of third-generation oral contraceptives.
DATA SOURCES: A medline search was done for English language articles published from …

A number of case-control studies published in recent years have shown an apparent
increase in the risk of venous thromboembolism (VTE) associated with the use of third …

Current users of combined oral contraceptives have an increased risk of venous
thromboembolism. The risk appears to be higher during the first year of use and disappears …

Objective: Three research articles published in late 1995 and early 1996 suggested that oral
contraceptives containing either of the newer progestogens (gestodene or desogestrel) …

A scientific discussion between 1995 and 1999 addressed the question whether second-
and third-generation oral contraceptives (OCs) were associated with different risks of venous …

Late in 1995 and early 1996, 4 epidemiologic studies were published that resulted in a
crude mean weighted relative risk of approximately 2 when third-generation oral …